Home Print this page Email this page Users Online: 242
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Year : 2014  |  Volume : 2  |  Issue : 3  |  Page : 216-218

Using etanercept to maintain remission of psoriatic arthritis during pregnancy

1 Department of medicine, College of Medicine, Al-Imam Mohammad Ibn Saud Islamic University, Riyadh, Saudi Arabia
2 Department of Medicine, Asir Central Hospital, Abha, Saudi Arabia

Correspondence Address:
Ibrahim A Al-Homood
College of Medicine, Al-Imam Mohammad Ibn Saud Islamic University, P.O. Box: 75227, Riyadh 11578
Saudi Arabia
Login to access the Email id

DOI: 10.4103/1658-631X.142582

Rights and Permissions

In recent years, biological drugs have been widely administered to treat rheumatic diseases including psoriatic arthritis (PsA). However, the safety of these drugs has not been adequately established in pregnancy. We report a case of a pregnant PsA patient treated with etanercept, an anti-tumor necrosis factor (TNF-α) agent. She continued to receive etanercept treatment during pregnancy without any complications, finally giving successful birth to a baby girl at 39 weeks. This suggests that etanercept may be selected to treat PsA patients with active arthritis who desire pregnancy with lower risks.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded155    
    Comments [Add]    

Recommend this journal